36.55
-0.03(-0.08%)
Currency In USD
| Previous Close | 36.58 |
| Open | 36.68 |
| Day High | 36.74 |
| Day Low | 34.57 |
| 52-Week High | 40.5 |
| 52-Week Low | 11.17 |
| Volume | 55,659 |
| Average Volume | 121,859 |
| Market Cap | 404.09M |
| PE | -17.57 |
| EPS | -2.08 |
| Moving Average 50 Days | 27.02 |
| Moving Average 200 Days | 20.93 |
| Change | -0.03 |
If you invested $1000 in Palvella Therapeutics, Inc. (PVLA) since IPO date, it would be worth $2,150 as of August 02, 2025 at a share price of $36.55. Whereas If you bought $1000 worth of Palvella Therapeutics, Inc. (PVLA) shares 0 years ago, it would be worth $2,150 as of August 02, 2025 at a share price of $36.55.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Palvella Therapeutics Added to Russell 3000® and Russell 2000® Indexes
GlobeNewswire Inc.
Jun 30, 2025 11:30 AM GMT
WAYNE, Pa., June 30, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: PVLA) Palvella Therapeutics, Inc. (Palvella), a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapies to treat patients suffering from serious, rare
Palvella Therapeutics Completes Enrollment in Phase 3 SELVA Trial of QTORIN™ Rapamycin for Microcystic Lymphatic Malformations, Exceeding Enrollment Target by Over 25%
GlobeNewswire Inc.
Jun 23, 2025 11:30 AM GMT
Enrollment of 51 subjects highlights significant unmet need in this serious, lifelong genetic disease which currently has no FDA-approved therapies Top-line data expected in the first quarter of 2026 WAYNE, Pa., June 23, 2025 (GLOBE NEWSWIRE) -- (N
Palvella Therapeutics Granted Sixth U.S. Patent Covering 0.1–20% Anhydrous Compositions of Rapamycin and Other mTOR Inhibitors
GlobeNewswire Inc.
Jun 18, 2025 11:30 AM GMT
New intellectual property builds on Palvella’s multi-layered exclusivity strategy Patent term expected through at least 2038 WAYNE, Pa., June 18, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: PVLA) Palvella Therapeutics, Inc. (Palvella), a clinical-stage bioph